Renal insufficiency: gadopentetate dimeglumine as a radiographic contrast agent during peripheral vascular interventional procedures

Radiology
J A KaufmanA C Waltman

Abstract

Gadopentetate dimeglumine diluted 1:1 with 0.9% normal saline was used as the radiographic contrast agent in two patients with azotemia who underwent peripheral vascular interventional procedures. The patients had no evidence of contrast material-induced renal failure after the procedures. The radiographic attenuation of the diluted gadopentetate dimeglumine was equivalent to diatrizoate meglumine diluted to 40 mg iodine per milliliter. Gadopentetate dimeglumine is an alternative radiographic contrast material for azotemic patients.

Citations

Sep 20, 2002·AJR. American Journal of Roentgenology·Alain-Ferdinand Le BlancheFrank Boudghene
Apr 27, 2001·Investigative Radiology·H J WagnerH Alfke
Mar 22, 2003·Investigative Radiology·Marc KalinowskiHans-Joachim Wagner
Mar 2, 1999·Journal of Computer Assisted Tomography·C S PeñaA C Waltman
Dec 10, 1999·Journal of Computer Assisted Tomography·T KawanoK Endo
Aug 9, 2001·Journal of Endovascular Therapy : an Official Journal of the International Society of Endovascular Specialists·G DangasM B Leon
Feb 5, 2000·Cardiovascular and Interventional Radiology·D J SpinosaA H Matsumoto
Apr 23, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Curtis W SlipmanEdward J Vresilovic
Mar 10, 2009·European Journal of Radiology·Dipanjan PanShelton D Caruthers
Oct 20, 2005·Applied Optics·Carlos A RabitoMark D Modell
Sep 21, 2000·Journal of Vascular and Interventional Radiology : JVIR·D J SpinosaG D Hartwell
Aug 2, 2003·Journal of Vascular Surgery·Albert D SamF Scott Pereles
Nov 3, 2005·Cardiovascular Revascularization Medicine : Including Molecular Interventions·Mohammad Sanaei-ArdekaniNasrollah Ghahramani
Aug 10, 2000·Journal of Magnetic Resonance Imaging : JMRI·V M Runge
Mar 6, 2003·Journal of Vascular Surgery·Gorav AilawadiGilbert R Upchurch
Aug 13, 2002·Radiologic Clinics of North America·David J SpinosaAlan H Matsumoto
Feb 15, 2001·The New England Journal of Medicine·R D Safian, S C Textor
Aug 23, 2002·Seminars in Dialysis·Alistair Cowie
Feb 10, 2009·Journal of Renal Care·Prajej RuangkanchanasetrThanom Supaporn
Feb 26, 2010·Physics in Medicine and Biology·F ArfelliR H Menk
Jun 30, 2002·Interventional Neuroradiology : Journal of Peritherapeutic Neuroradiology, Surgical Procedures and Related Neurosciences·M JacamonJ F Bonneville
Oct 13, 2009·Postgraduate Medicine·Hariprasad TrivediRuchika Batwara
Jun 28, 2012·Human & Experimental Toxicology·C-C ChienJ-J Wang
Dec 26, 2001·Chemical Reviews·S B Yu, A D Watson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.